ENXTPA:VETOPharmaceuticals
Vetoquinol (ENXTPA:VETO) Valuation After 2025 Sales Update And Recent Share Price Strength
Vetoquinol (ENXTPA:VETO) has released unaudited sales for the fourth quarter and full year 2025, with quarterly revenue at €141.5 million and full year sales at €525.7 million, compared with €539.2 million in 2024.
See our latest analysis for Vetoquinol.
The latest sales update lands after a period where momentum in Vetoquinol’s share price has been picking up. The 90 day share price return is 19.72% and the 1 year total shareholder return is 24.24%, even though the 5 year total shareholder...